BioAffinity Technologies Inc (NASDAQ:BIAF)’s traded shares stood at 5.08 million during the last session, with the company’s beta value hitting 2.54. At the close of trading, the stock’s price was $0.29, to imply an increase of 10.06% or $0.03 in intraday trading. The BIAF share’s 52-week high remains $2.99, putting it -931.03% down since that peak but still an impressive 44.83% since price per share fell to its 52-week low of $0.16. The company has a valuation of $8.25M, with an average of 22.04 million shares in intraday trading volume over the past 10 days and average of 7.34 million shares over the past 3 months.
BioAffinity Technologies Inc (NASDAQ:BIAF) trade information
After registering a 10.06% upside in the last session, BioAffinity Technologies Inc (BIAF) has traded red over the past five days. The 5-day price performance for the stock is 18.37%, and 10.39% over 30 days. With these gigs, the year-to-date price performance is -86.57%. Short interest in BioAffinity Technologies Inc (NASDAQ:BIAF) saw shorts transact 0.77 million shares and set a 0.1 days time to cover.
BIAF Dividends
BioAffinity Technologies Inc has its next earnings report out on 2025-May-15. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
BioAffinity Technologies Inc (NASDAQ:BIAF)’s Major holders
BioAffinity Technologies Inc insiders hold 24.52% of total outstanding shares, with institutional holders owning 1.80% of the shares at 2.38% float percentage. In total, 1.80% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 0.17 million shares (or 1.5101% of shares), all amounting to roughly $0.37 million.
The next major institution holding the largest number of shares is GEODE CAPITAL MANAGEMENT, LLC with 69600.0 shares, or about 0.6111% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.15 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the BioAffinity Technologies Inc (BIAF) shares. Going by data provided on Mar 31, 2025 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 136.25 shares. This is just over 0.48% of the total shares, with a market valuation of $39513.0. Data from the same date shows that the other fund manager holds a little less at 68.81, or 0.24% of the shares, all valued at about 19954.0.
